|
SGMS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.736700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.882970E-01 |
| Normal-vs-Stage2 |
1.091200E-01 |
| Normal-vs-Stage3 |
9.797900E-03 |
| Normal-vs-Stage4 |
5.67870000000026E-05 |
| Stage1-vs-Stage2 |
3.384000E-01 |
| Stage1-vs-Stage3 |
6.097700E-02 |
| Stage1-vs-Stage4 |
1.177420E-03 |
| Stage2-vs-Stage3 |
6.557400E-01 |
| Stage2-vs-Stage4 |
2.819000E-01 |
| Stage3-vs-Stage4 |
5.064400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.862900E-03 |
| Normal-vs-AfricanAmerican |
1.684470E-02 |
| Normal-vs-Asian |
5.503400E-01 |
| Caucasian-vs-AfricanAmerican |
4.178600E-01 |
| Caucasian-vs-Asian |
7.798800E-01 |
| AfricanAmerican-vs-Asian |
5.397000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.600350E-03 |
| Normal-vs-Female |
9.547900E-02 |
| Male-vs-Female |
1.664770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.962300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.135700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.275650E-02 |
| Normal-vs-Age(81-100Yrs) |
1.375770E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.801400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.685800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.251600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.902800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.316200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.551200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.022200E-01 |
| Normal-vs-Grade 2 |
4.265000E-01 |
| Normal-vs-Grade 3 |
9.355100E-04 |
| Normal-vs-Grade 4 |
3.22700000054965E-08 |
| Grade 1-vs-Grade 2 |
7.396400E-01 |
| Grade 1-vs-Grade 3 |
4.741800E-01 |
| Grade 1-vs-Grade 4 |
2.129500E-02 |
| Grade 2-vs-Grade 3 |
2.779700E-02 |
| Grade 2-vs-Grade 4 |
4.01740000000039E-06 |
| Grade 3-vs-Grade 4 |
5.084300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.252600E-01 |
| Normal-vs-ccB subtype |
6.884400E-03 |
| ccA subtype-vs-ccB subtype |
1.093830E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.151800E-02 |
| Normal-vs-N1 |
1.762840E-01 |
| N0-vs-N1 |
6.244600E-01 |
|
|
